NVCRNovoCure Ltdvs its industry peers
A metric-by-metric comparison of NovoCure Ltd against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVCR본 종목 | $1.9B#6 | — | 5.6x#9 | 2.9x#7 | 8.3%#11 | 19.4%#6 | -23.5%#10 | -40.3%#9 | -35.0%#9 | 3#9 | — | — |
| HTFL | $4.2B#1 | 16.2x#1 | 15.0x#13 | 23.9x#14 | 39.9%#2 | -21.1%#12 | -36.4%#13 | -41.8%#10 | — | — | — | — |
| ICUI | $3.9B#2 | 131.0x#6 | 1.8x#2 | 1.7x#3 | -6.3%#14 | 100.6%#3 | 1.9%#6 | 0.0%#6 | 0.3%#4 | 6#4 | 18.0%#3 | — |
| ATRC | $2.9B#3 | 267.9x#7 | 5.5x#8 | 5.4x#10 | 14.9%#6 | 74.4%#4 | -1.8%#7 | -2.2%#8 | -2.3%#5 | 7#1 | 62.4%#1 | — |
| INSP | $2.2B#4 | 16.5x#2 | 2.6x#3 | 2.4x#5 | 13.6%#8 | 171.8%#2 | 5.6%#5 | 17.6%#2 | 7.1%#2 | 7#1 | — | — |
| UFPT | $2.1B#5 | 29.9x#4 | 4.6x#7 | 3.6x#8 | 19.5%#5 | 15.8%#8 | 15.3%#3 | 14.8%#3 | 13.4%#1 | 7#1 | — | — |
| LMAT | $1.8B#7 | 28.0x#3 | 4.4x#6 | 7.3x#11 | 13.5%#10 | 31.1%#5 | 27.2%#2 | 13.7%#4 | — | — | — | 1.0%#2 |
| ATEC | $1.6B#8 | — | — | 2.2x#4 | 25.0%#4 | 11.6%#9 | -10.7%#8 | — | -18.5%#6 | 6#4 | -29.1%#5 | — |
| KMTS | $1.5B#9 | — | 6.8x#10 | 15.8x#13 | 59.0%#1 | -15.6%#11 | -141.6%#14 | -59.2%#12 | -59.5%#10 | 4#8 | — | — |
| AORT | $1.2B#10 | — | 2.8x#4 | 2.8x#6 | 13.6%#9 | 173.1%#1 | 7.6%#4 | 2.2%#5 | 3.0%#3 | 5#7 | -36.0%#6 | 0.3%#3 |
| IART | $1.2B#11 | — | 1.2x#1 | 0.7x#1 | 1.5%#13 | -7389.9%#14 | -30.2%#11 | -49.5%#11 | -32.1%#8 | 6#4 | 3.9%#4 | — |
| TNDM | $1.1B#12 | — | 8.7x#11 | 1.1x#2 | 7.9%#12 | -113.2%#13 | -18.5%#9 | -157.0%#13 | -26.3%#7 | 3#9 | 34.8%#2 | — |
| PRCT | $1.1B#13 | — | 3.2x#5 | 3.6x#9 | 37.2%#3 | -4.5%#10 | -33.7%#12 | -0.0%#7 | -63.4%#11 | 2#11 | — | — |
| IRMD | $1.1B#14 | 46.0x#5 | 10.3x#12 | 12.6x#12 | 14.4%#7 | 16.9%#7 | 31.2%#1 | 22.1%#1 | — | — | — | 1.4%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice